產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
產(chǎn)品概述
| 名稱 | HuH-7 (人肝癌細(xì)胞) (STR鑒定正確) |
| 別稱 | HuH-7; HUH-7; HuH7; Huh7; HUH7; JTC-39; Japanese Tissue Culture-39 |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | 據(jù)說(shuō)，HuH-7細(xì)胞可產(chǎn)甲胎蛋白、胰酶α抗體、血漿銅藍(lán)蛋白、纖維蛋白原、纖維粘連蛋白等。 |
| 年齡（性別） | 男性；57歲 |
| 組織來(lái)源 | 肝；肝癌 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 肝膽癌細(xì)胞 |
| 保藏機(jī)構(gòu) | CCLV; CCLV-RIE 1079 JCRB; JCRB0403 KCB; KCB 200970YJ KCLB; 60104 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 11 D2S1338 19 D3S1358 15 D5S818 12 D7S820 11 D8S1179 14 D13S317 10,11 D16S539 10 D18S51 15 D19S433 13,14 D21S11 30 FGA 22,23 PentaD 12 PentaE 11 TH01 7 TPOX 8,11 vWA 16,18 D6S1043 13,15 D12S391 20,21 D2S441 12,14 -
STR鑒定圖
-
參考文獻(xiàn)
-
Lung cancer shapes commensal bacteria via exosome-like nanoparticles(2022/03/17)
作者：Jipeng Jianga, Jie Mei, Shasha Jiang
期刊：Nano Today
DOI：10.1016/j.nantod.2022.101451
影響因子 ：18.962
-
The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP(2023/10/12)
作者：Zelin Tian, Chen Xu, Weixiang He
期刊：CANCER LETTERS
DOI：10.1016/j.canlet.2023.216439
影響因子 ：9.700
引用產(chǎn)品：CL-0120
-
ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma(2022/09/19)
作者：Kejie He, Yangfan Zhang, Laiying Liang
期刊：Molecular Therapy-Nucleic Acids
DOI：10.1016/j.omtn.2022.09.007
影響因子 ：8.800
-
A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma(2022/09/06)
作者：Shenglan Huang, Liying Sun, Ping Hou
期刊：Frontiers in Immunology
影響因子 ：8.786
引用產(chǎn)品：CL-0120
-
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway(2021/11/27)
作者：Ying Xing,Yang Liu，Zhong Qi
期刊：Cellular & Molecular Biology Letters
DOI：10.1186/s11658-021-00295-4
影響因子 ：8.300
-
Visualization system based on hierarchical targeting for diagnosis and treatment of hepatocellular carcinoma(2022/08/22)
作者：Shasha Shi, Huipu Li, Xi Zheng
期刊：Materials Today Bio
DOI：10.1016/j.mtbio.2022.100398
影響因子 ：8.200
-
5′-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I(2023/03/28)
作者：Chengdong Wu, Dekai Liu, Lufei Zhang
期刊：Frontiers of Medicine
影響因子 ：8.100
-
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4(2023/12/01)
作者：Chun Wang, Zhihang Chen, Yun Yi
期刊：ONCOGENE
DOI：10.1038/s41388-023-02902-4
影響因子 ：8.000
引用產(chǎn)品：CL-0120
-
Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination(2023/11/25)
作者：Kun Cao, Ruonan Wang, Lianhai Li
期刊：ONCOGENE
DOI：10.1038/s41388-023-02898-x
影響因子 ：8.000
引用產(chǎn)品：CL-0120
-
Upregulation of UGT1A1 expression by ursolic acid and oleanolic acid via the inhibition of the PKC/NF-κB signaling pathway(2021/08/25)
作者：Li Yuan, Lingming Zhang, Na Yao
期刊：Phytomedicine
DOI：10.1016/j.phymed.2021.153726
影響因子 ：7.900
-
SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis(2024/03/01)
作者：Youpeng Wang, Ziyin Zhao, Tingting Guo
期刊：npj Precision Oncology
DOI：10.1038/s41698-024-00545-6
影響因子 ：7.900
引用產(chǎn)品：CL-0120
-
Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90α, and RXRα (2022/04/06)
作者：Lingming Zhang, Jingdi Yan, Jianming Liu
期刊：PHYTOMEDICINE
DOI：10.1016/j.phymed.2022.154097
影響因子 ：7.900
-
Porous hydrogel arrays for hepatoma cell spheroid formation and drug resistance investigation(2021/07/17)
作者：Xin Lei, Changmin Shao, Xin Shou
期刊：Bio-Design and Manufacturing
DOI：10.1007/s42242-021-00141-8
影響因子 ：7.900
引用產(chǎn)品：CL-0120
-
Glycolysis, a new mechanism of oleuropein against liver tumor(2023/03/15)
作者：Zongchao Hong, Yi Lu, Bo Liu
期刊：PHYTOMEDICINE
DOI：10.1016/j.phymed.2023.154770
影響因子 ：7.900
-
How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study(2024/03/11)
作者：Yanlong Shi, Yizhu Wang, Kaiyi Niu
期刊：COMPUTERS IN BIOLOGY AND MEDICINE
DOI：10.1016/j.compbiomed.2024.108260
影響因子 ：7.700
引用產(chǎn)品：CL-0120
-
Design and synthesis of nucleotidyl lipids and their application in the targeted delivery of siG12D for pancreatic cancer therapy(2024/02/06)
作者：Yufei Pan, Yuejie Zhu, Yuan Ma
期刊：BIOMEDICINE & PHARMACOTHERAPY
DOI：10.1016/j.biopha.2024.116239
影響因子 ：7.500
引用產(chǎn)品：CL-0120
-
RBBP7, regulated by SP1, enhances the Warburg effect to facilitate the proliferation of hepatocellular carcinoma cells via PI3K/AKT signaling(2024/02/18)
作者：Yuan Fang, WeiQiang Tang, Siming Qu
期刊：Journal of Translational Medicine
DOI：10.1186/s12967-024-04964-8
影響因子 ：7.400
引用產(chǎn)品：CL-0120
-
JMJD6–BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells(2023/10/25)
作者：Ruifeng Pei, Le Zhao, Yiren Ding
期刊：Journal of Translational Medicine
DOI：10.1186/s12967-023-04394-y
影響因子 ：7.400
引用產(chǎn)品：CL-0120
-
Arginine methylation of HSPA8 by PRMT9 inhibits ferroptosis to accelerate hepatitis B virus-associated hepatocellular carcinoma progression(2023/09/15)
作者：Wensheng Deng, Jiaoyu Ai, Wanlin Zhang
期刊：Journal of Translational Medicine
DOI：10.1186/s12967-023-04408-9
影響因子 ：7.400
-
Precise Detection on Cell–Cell Fusion by a Facile Molecular Beacon-Based Method(2022/12/01)
作者：Chang Xu, Xiaohe Ren, Di Han
期刊：Analytical Chemistry
DOI：10.1021/acs.analchem.2c04852
影響因子 ：7.400
-
DNAJC8: a prognostic marker and potential therapeutic target for hepatocellular carcinoma(2024/01/11)
作者：Zhibo Zhang, Mingxiu Ju, Zhongming Tang
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1289548
影響因子 ：7.300
引用產(chǎn)品：CL-0120
-
The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC(2023/04/26)
作者：Jianming Dong, Rongzheng Zhang, Yan Xia
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1142319
影響因子 ：7.300
-
Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles(2022/12/26)
作者：Jun Deng, Hui Ke
期刊：OncoImmunology
DOI：10.1080/2162402X.2022.2152635
影響因子 ：7.200
-
Constructing a disulfidptosis-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing and weighted co-expression network analysis(2024/05/17)
作者：Zelin Tian, Junbo Song, Jiang She
期刊：APOPTOSIS
DOI：10.1007/s10495-024-01968-z
影響因子 ：7.200
引用產(chǎn)品：CL-0120
-
Discovery of New Triterpenoids Extracted from Camellia oleifera Seed Cake and the Molecular Mechanism Underlying Their Antitumor Activity(2022/12/21)
作者：Zelong Wu, Xiaofeng Tan, Junqin Zhou
期刊：Antioxidants
影響因子 ：7.000
-
Transfer RNA‐derived fragment 5′tRF‐Gly promotes the development of hepatocellular carcinoma by direct targeting of carcinoembryonic antigen‐related cell adhesion molecule 1(2022/08/16)
作者：Dekai Liu, Chengdong Wu, Jingjie Wang
期刊：CANCER SCIENCE
影響因子 ：6.518
引用產(chǎn)品：CL-0120
-
VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4(2022/10/14)
作者：Xiaobao Shi, Pengfei Zhao, Gang Zhao
期刊：Cancer Gene Therapy
DOI：10.1038/s41417-022-00540-8
影響因子 ：6.400
-
A triggered DNA nanomachine with enzyme-free for the rapid detection of telomerase activity in a one-step method(2024/02/27)
作者：Huajie Pang, Yanan Peng, Rui Zhang
期刊：ANALYTICA CHIMICA ACTA
影響因子 ：6.200
引用產(chǎn)品：CL-0120
-
Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis(2023/08/23)
作者：Fangming Liu, Yuting Wu, Baohui Zhang
期刊：CHINESE MEDICAL JOURNAL
DOI：10.1097/CM9.0000000000002816
影響因子 ：6.100
-
Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model.(2022/10/14)
作者：Lidan Luo, Shuai Wang, Bohao Chen
期刊：Frontiers in Pharmacology
影響因子 ：5.988
引用產(chǎn)品：CL-0120
-
Construction of cuproptosis-related lncRNAs/mRNAs model and prognostic prediction of hepatocellular carcinoma(2022/10/15)
作者：Lingxue Tang, Tong Wang, Wen Li
期刊：American Journal of Cancer Research
DOI：PMID:36381337
影響因子 ：5.942
引用產(chǎn)品：CL-0120
-
Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+(2023/03/11)
作者：Xuexia Yuan, Youfa Duan, Chunxiang Luo
期刊：BIOCHEMICAL PHARMACOLOGY
影響因子 ：5.800
-
CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasis(2023/02/02)
作者：Bei Zhang, Zhiyao Ren, Hongmei Zheng
期刊：iScience
DOI：10.1016/j.isci.2023.106099
影響因子 ：5.800
-
CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway(2024/01/09)
作者：Zhengchen Jiang, Bowen Shi, Yun Zhang
期刊：iScience
DOI：10.1016/j.isci.2024.108843
影響因子 ：5.800
引用產(chǎn)品：CL-0120
-
Tanshinone I induces cell apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing p53/DRAM-mediated autophagy in human hepatocellular carcinoma(2020/2/4)
作者：Xu Liu, JiKui Liu
期刊：Artificial Cells Nanomedicine and Biotechnology
DOI：10.1080/21691401.2019.1709862
影響因子 ：5.800
-
Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients(2022/06/06)
作者：Xianbin Wu,?Zhejun Deng,?Xiaomin Liao?
期刊：Frontiers in Oncology
影響因子 ：5.738
-
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway(2024/03/12)
作者：Bo Shu, Yingxia Zhou, Guoqiong Lei
期刊：CANCER SCIENCE
影響因子 ：5.700
引用產(chǎn)品：CL-0120
-
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma(2024/02/13)
作者：Meiying Song, Luoyang Wang, Suli Jiang
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2024.111601
影響因子 ：5.600
引用產(chǎn)品：CL-0120
-
FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mTORC1 Signaling Pathway(2023/11/24)
作者：Yaofeng Wang, Gengqiao Wang, Shaobo Hu
期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影響因子 ：5.600
引用產(chǎn)品：CL-0120
-
Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5(2019/09/19)
作者：Yan Sun, Hai Sun
期刊：Journal Of Cellular Physiology
影響因子 ：5.600
-
BMP9-ID1 Pathway Attenuates N6-Methyladenosine Levels of CyclinD1 to Promote Cell Proliferation in Hepatocellular Carcinoma(2024/01/12)
作者：Han Chen, Mingming Zhang, Jianhao Li
期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影響因子 ：5.600
引用產(chǎn)品：CL-0120
-
The E3 ubiquitin ligase SOCS-7 reverses immunosuppression via Shc1 signaling in hepatocellular carcinoma(2022/01/18)
作者：Peixin Huang, Zhiying Zhao, Yi Chen
期刊：Laboratory Investigation
DOI：10.1038/s41374-022-00727-5
影響因子 ：5.502
-
Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis(2023/10/24)
作者：Ran Liu, Chuanzheng Yin, Peng Zhao
期刊：Biology Direct
DOI：10.1186/s13062-023-00428-z
影響因子 ：5.500
引用產(chǎn)品：CL-0120
-
Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α(2021/09/01)
作者：Meng Wang, Haoyu Liu, Xu Zhang
期刊：Frontiers in Cell and Developmental Biology
影響因子 ：5.500
-
Liuwei Wuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signalling pathway(2023/11/11)
作者：Yuanyuan Chen, Zheng Song, Xiaorong Hou
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：5.400
引用產(chǎn)品：CL-0120
-
The bioactive ingredients in Actinidia chinensis Planch. Inhibit liver cancer by inducing apoptosis(2021/08/21)
作者：Zongchao Hong, Yi Lu, Chongwang Ran
期刊：Journal Of Ethnopharmacology
影響因子 ：5.400
-
PRDM16 from hepatic stellate cells-derived extracellular vesicles promotes hepatocellular carcinoma progression(2023/11/15)
作者：Chen Sun, Wenwen Xu, Yunhong Xia
期刊：American Journal of Cancer Research
DOI：PMID:38058806
影響因子 ：5.300
引用產(chǎn)品：CL-0120
-
Integrated analysis of lactate-related genes identifies POLRMT as a novel marker promoting the proliferation, migration and energy metabolism of hepatocellular carcinoma via Wnt/β-Catenin signaling(2024/03/15)
作者：Huifen Wang, Yanli Zhang, Shiyu Du
期刊：American Journal of Cancer Research
影響因子 ：5.300
引用產(chǎn)品：CL-0120
-
Upregulation of FAM134B inhibits endoplasmic reticulum stress-related degradation protein expression and promotes hepatocellular carcinogenesis(2023/09/20)
作者：Houhong Wang, Lu Liu, Huihui Gong
期刊：JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
影響因子 ：5.300
-
Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.(2020/05/28)
作者：Yong Wang, Rongfen Gao, Jinpeng Li
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：CL-0120
-
Astaxanthin Augmented the Anti-Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibition of the JAK2/STAT3 Signaling Pathway and Mitigation of Hypoxia within the Tumor Microenvironment(2023/12/07)
作者：Pengfei Ren, Qingjuan Tang, Xinjia He
期刊：MOLECULAR NUTRITION & FOOD RESEARCH
影響因子 ：5.200
引用產(chǎn)品：CL-0120
-
Coptisine-mediated downregulation of E2F7 induces G2/M phase arrest in hepatocellular carcinoma cells through inhibition of E2F4/NFYA/NFYB transcription factors(2024/05/23)
作者：Hongmei Wang, Zhengcai Ma, Minmin Xu
期刊：CHEMICO-BIOLOGICAL INTERACTIONS
影響因子 ：5.100
引用產(chǎn)品：CL-0120
-
Calycosin-7-glucoside promotes mitochondria-mediated apoptosis in hepatocellular carcinoma by targeting thioredoxin 1 to regulate oxidative stress(2023/02/21)
作者：Xiaodong Wei, Yanping Zeng, Fancheng Meng
期刊：CHEMICO-BIOLOGICAL INTERACTIONS
影響因子 ：5.100
引用產(chǎn)品：164210 CL-0103 CL-0120 PB180120 PM150210 PM150410
-
Synthesis and preclinical evaluation of a novel probe [18F]AlF-NOTA-IPB-GPC3P for PET imaging of GPC3 positive tumor(2024/04/14)
作者：Chunwei Mo, Penghui Sun, Haoran Liang
期刊：BIOORGANIC CHEMISTRY
DOI：10.1016/j.bioorg.2024.107352
影響因子 ：5.100
引用產(chǎn)品：CL-0120
-
Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression(2023/09/18)
作者：Can Jiang, Chunyang Zhang, Min Dai
期刊：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
DOI：10.1016/j.bbamcr.2023.119595
影響因子 ：5.100
引用產(chǎn)品：CL-0120
-
Asymmetric total synthesis and anti-hepatocellular carcinoma profile of enantiopure euphopilolide and jolkinolide E(2023/06/22)
作者：Xin Li, Jian Chen, Kaixuan Luo
期刊：BIOORGANIC CHEMISTRY
DOI：10.1016/j.bioorg.2023.106688
影響因子 ：5.100
-
Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β-catenin signaling pathway(2022/02/07)
作者：Chaohui Liu, Jiansheng Pan, Hongyu Liu
期刊：Drug Development Research
影響因子 ：5.004
-
ZMIZ1 upregulation of TET3-mediated hydroxymethylation induces M2 polarization of Kupffer cells in hepatocellular carcinogenesis by mediating Notch1/c-Myc signaling(2023/10/13)
作者：Jia Liu, Tingting Sun, Linan Yin
期刊：LABORATORY INVESTIGATION
DOI：10.1016/j.labinv.2023.100264
影響因子 ：5.000
引用產(chǎn)品：CL-0120
-
Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma(2023/12/01)
作者：Kejie He, Guoyu Gong, E Liang
期刊：Translational Oncology
DOI：10.1016/j.tranon.2023.101844
影響因子 ：5.000
引用產(chǎn)品：CL-0120
-
CREB3 facilitates Donafenib resistance in hepatocellular carcinoma cells via the LSD1/CoREST/p65 axis by transcriptionally activating long noncoding RNA ZFAS1(2023/11/29)
作者：Xunbo Hou, Qiannan Xu, Ruibao Liu
期刊：Translational Oncology
DOI：10.1016/j.tranon.2023.101684
影響因子 ：5.000
引用產(chǎn)品：CL-0120
-
SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma(2022/11/14)
作者：Zuyi Ma, Zhenchong Li, Shujie Wang
期刊：Journal of Hepatocellular Carcinoma
影響因子 ：4.962
引用產(chǎn)品：CL-0120
-
Deciphering the immunological and prognostic features of hepatocellular carcinoma through ADP-ribosylation–related genes analysis and identify potential therapeutic target ARFIP2(2024/01/30)
作者：Fenfen Jiang, Yan Xu, Zhuang Jiang
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2024.111073
影響因子 ：4.800
引用產(chǎn)品：CL-0120
-
FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma(2023/07/28)
作者：Meifang Song, Luyuan Ma, Chuan Shen
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2023.110828
影響因子 ：4.800
-
System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma(2023/09/13)
作者：Kejie He, Zhiqiang Nie
期刊：Frontiers in Oncology
影響因子 ：4.700
-
Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis(2023/04/06)
作者：Qilin Meng, Lin Luo, Minghua Lei
期刊：Pharmaceuticals
影響因子 ：4.600
-
Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC(2023/03/15)
作者：Lilan Fan, Panpan Xia, Jing Wang
期刊：MOLECULAR CARCINOGENESIS
DOI：10.1002/mc.23526
影響因子 ：4.600
-
Sorafenib/2800Z Co-Loaded into Cholesterol and PEG Grafted Polylysine NPs for Liver Cancer Treatment(2023/01/13)
作者：Chen Zhang, Wu Zhong, Ying Cao
期刊：Pharmaceuticals
影響因子 ：4.600
引用產(chǎn)品：CL-0120
-
KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma(2022/12/05)
作者：Zichang Dai, Qiyuan Huang, Xueran Huang
期刊：MOLECULAR CARCINOGENESIS
DOI：10.1002/mc.23492
影響因子 ：4.600
-
Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496/programmed cell death ligand 1 axis in an m6A-dependent manner(2024/03/28)
作者：Furong Yu, Peifei Fang, Yonghong Fang
期刊：ENVIRONMENTAL TOXICOLOGY
影響因子 ：4.500
引用產(chǎn)品：CL-0120
-
Matrine suppresses hepatocellular carcinoma tumorigenesis by modulating circ_0055976/miR-1179/lactate dehydrogenase A axis(2023/11/23)
作者：Xinfeng Chang, Hongwei Li, Zhengchun Huang
期刊：ENVIRONMENTAL TOXICOLOGY
影響因子 ：4.500
引用產(chǎn)品：CL-0120
-
Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1(2022/02/17)
作者：Hongyang Shi, Yonghong Zhang, Yu Wang
期刊：Toxicology And Applied Pharmacology
DOI：10.1016/j.taap.2022.115926
影響因子 ：4.460
-
Role of autophagy-related genes in liver cancer prognosis(2024/05/03)
作者：Yuling Zhou, Rong Shan, Wangti Xie
期刊：GENOMICS
DOI：10.1016/j.ygeno.2024.110852
影響因子 ：4.400
引用產(chǎn)品：CL-0120
-
CDK1-SRC Interaction-Dependent Transcriptional Activation of HSP90AB1 Promotes Antitumor Immunity in Hepatocellular Carcinoma(2023/11/10)
作者：Yijie Zhang, Dehui Yi
期刊：JOURNAL OF PROTEOME RESEARCH
DOI：10.1021/acs.jproteome.3c00379
影響因子 ：4.400
引用產(chǎn)品：CL-0120
-
Ultrasound-Targeted Microbubble Destruction-Mediated Downregulation of EZH2 Inhibits Stemness and Epithelial-Mesenchymal Transition of Liver Cancer Stem Cells(2021/01/11)
作者：Jie Wu, Lulu Sun, Tingting Liu
期刊：OncoTargets and Therapy
影響因子 ：4.345
引用產(chǎn)品：CL-0120
-
MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination(2023/07/05)
作者：Hengzheng He, Jian Zhou, Fahui Cheng
期刊：Human Cell
DOI：10.1007/s13577-023-00945-z
影響因子 ：4.300
-
ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway(2021/06/07)
作者：Jianwen Liu, Ruiqing Liu, Yuyan Liu
期刊：Cell Cycle
DOI：10.1080/15384101.2021.1919828
影響因子 ：4.300
-
β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression(2024/05/30)
作者：Ruoyu Wang, Dan Tang, Longyun Ou
期刊：Human Cell
DOI：10.1007/s13577-024-01081-y
影響因子 ：4.300
引用產(chǎn)品：CL-0120
-
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p(2023/06/07)
作者：Lu Li, Rong Ai, Xiwei Yuan
期刊：Journal of Hepatocellular Carcinoma
影響因子 ：4.100
-
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro(2024/03/19)
作者：Yuanqin Du, Bin Yuan, Yixian Ye
期刊：Journal of Hepatocellular Carcinoma
影響因子 ：4.100
引用產(chǎn)品：CL-0120
-
Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents(2024/02/13)
作者：Yu He, Sisi Zhang, Mengxue Wei
期刊：RSC Medicinal Chemistry
影響因子 ：4.100
引用產(chǎn)品：CL-0120
-
Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis.(2023/06/09)
作者：Yan Feng, Shufeng Xia, Junlan Hui
期刊：Heliyon
DOI：10.1016/j.heliyon.2023.e17120
影響因子 ：4.000
-
Exploring immune evasion of SARS-CoV-2 variants using a pseudotyped system(2024/04/18)
作者：Haixiao Duan, Ershuai Zhang, Ge Ren
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e29939
影響因子 ：4.000
引用產(chǎn)品：CL-0120
-
Long noncoding RNA HULC regulates the NF-κB pathway and represents a promising prognostic biomarker in liver cancer(2022/10/10)
作者：Shihai Liu, Lakshmi Huttad, Guifang He
期刊：Cancer Medicine
影響因子 ：4.000
-
Exosome-derived miR-23a-5p inhibits HCC proliferation and angiogenesis by regulating PRDX2 expression: MiR-23a-5p/PRDX2 axis in HCC progression.(2023/12/02)
作者：Yang Zhao, Jun Liu, Zhengping Xiong
期刊：Heliyon
DOI：10.1016/j.heliyon.2023.e23168
影響因子 ：4.000
引用產(chǎn)品：CL-0120
-
Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation(2024/01/20)
作者：Wei Huang, Chenyang Wang, Hui Zhang
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e24401
影響因子 ：4.000
引用產(chǎn)品：CL-0120
-
Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses(2023/08/22)
作者：Chang Su, Jingcheng Yang, Zheng Rong
期刊：Heliyon
DOI：10.1016/j.heliyon.2023.e19233
影響因子 ：4.000
引用產(chǎn)品：CL-0120
-
Modifying aluminum phthalocyanine with quantum dots to promote cellular uptake and enhance the efficacy of anticancer photodynamic therapy(2022/12/14)
作者：Lei Li, Dai Bin, Han Ting
期刊：Frontiers in Materials
DOI：10.3389/fmats.2022.1056212
影響因子 ：3.985
引用產(chǎn)品：CL-0120
-
c-Jun-mediated JMJD6 restoration enhances resistance of liver cancer to radiotherapy through the IL-4-activated ERK pathway(2023/04/18)
作者：Yong Liu, Aixia Sui, Jirui Sun
期刊：CELL BIOLOGY INTERNATIONAL
影響因子 ：3.900
-
The expression characteristics and clinical significance of ACP6, a potential target of nitidine chloride, in hepatocellular carcinoma(2022/12/01)
作者：Li Gao, Dandan Xiong, Xia Yang
期刊：BMC CANCER
DOI：10.1186/s12885-022-10292-1
影響因子 ：3.800
引用產(chǎn)品：CL-0120
-
Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2(2023/02/07)
作者：Shuaishuai Cui, Yuanyuan Chen, Yunfei Guo
期刊：PLoS One
DOI：10.1371/journal.pone.0281536
影響因子 ：3.700
引用產(chǎn)品：CL-0120
-
AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics(2021/12/03)
作者：Xiaoling Liu,?Chenyu Wang,?Qing Yang?
期刊：Frontiers in Genetics
影響因子 ：3.700
-
miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2(2024/02/23)
作者：Mingzhi Xia, Jie Chen, Yingyun Hu
期刊：CANCER BIOLOGY & THERAPY
DOI：10.1080/15384047.2024.2315651
影響因子 ：3.600
引用產(chǎn)品：CL-0120
-
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma(2024/05/09)
作者：Kai You, Xingxing Du, Yunzheng Zhao
期刊：JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI：10.1007/s00432-024-05756-9
影響因子 ：3.600
引用產(chǎn)品：CL-0120
-
Atractylenolide II regulates the proliferation, ferroptosis, and immune escape of hepatocellular carcinoma cells by inactivating the TRAF6/NF-κB pathway(2024/05/06)
作者：Yujie Lin, Ke Chen, Min Zhu
期刊：NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
DOI：10.1007/s00210-024-03046-2
影響因子 ：3.600
引用產(chǎn)品：CL-0120
-
BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1(2023/06/29)
作者：Peng Wang, Jianmin Sun, Chengming Sun
期刊：CANCER BIOLOGY & THERAPY
DOI：10.1080/15384047.2023.2225884
影響因子 ：3.600
-
lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2(2023/10/18)
作者：Shouzhang Yang, Xiaojiao Ruan, Bingren Hu
期刊：CELL AND TISSUE RESEARCH
DOI：10.1007/s00441-023-03834-x
影響因子 ：3.600
引用產(chǎn)品：CL-0120
-
HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p(2023/10/25)
作者：Chuntang Qin, Shuyan Liu, Weibin Chen
期刊：NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
DOI：10.1007/s00210-023-02793-y
影響因子 ：3.600
引用產(chǎn)品：CL-0120
-
Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation(2023/03/04)
作者：Xiao Han, Jiayan Huang, Jia Lu
期刊：NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
DOI：10.1007/s00210-023-02432-6
影響因子 ：3.600
-
PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway(2021/10/30)
作者：Gang Zhao, Xiaobao Shi, Zhanbo Sun
期刊：Acta Biochimica Et Biophysica Sinica
影響因子 ：3.511
-
PSPC1 regulates CHK1 phosphorylation through phase separation and participates in mouse oocyte maturation(2021/09/07)
作者：Li Jiong, Cui Peng, Sun Qi
期刊：Acta Biochimica Et Biophysica Sinica
影響因子 ：3.511
-
LncRNA FAM13A-AS1, transcriptionally regulated by PHOX2B, modulates hepatocellular carcinoma chemoresistance via stabilizing PPARγ(2023/06/16)
作者：Daowen Ye, Jun Ma, Tingdong Yu
期刊：GENE
DOI：10.1016/j.gene.2023.147570
影響因子 ：3.500
-
Complement factor H?related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis(2019/7/23)
作者：Hong Liu, Ligang Zhang, Pengyan Wang
期刊：Molecular Medicine Reports
影響因子 ：3.400
引用產(chǎn)品：CL-0120
-
LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma(2023/08/04)
作者：Xuejie Li, Yuqin Wu, Pingfeng Wang
期刊：Clinical & Translational Oncology
DOI：10.1007/s12094-023-03294-3
影響因子 ：3.400
-
Combining a glycolysis?related prognostic model based on scRNA?Seq with experimental verification identifies ZFP41 as a potential prognostic biomarker for HCC(2024/03/19)
作者：Yu Teng, Jianrong Xu, Yaoqun Wang
期刊：Molecular Medicine Reports
影響因子 ：3.400
引用產(chǎn)品：CL-0120
-
Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis(2020/07/14)
作者：Wei Liu, Changbin Yin, Yue Liu
期刊：CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影響因子 ：3.400
引用產(chǎn)品：CL-0120
-
Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis(2020/03/12)
作者：Huaqiang Bi, Zhonghui Li, Hui Zhang
期刊：Hepatobiliary & Pancreatic Diseases International
DOI：10.1016/j.hbpd.2020.02.011.
影響因子 ：3.300
-
Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma(2022/01/25)
作者：Xu Qian, Zhongming Bao, Dan Yao
期刊：Kaohsiung Journal of Medical Sciences
影響因子 ：3.300
-
CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis(2023/01/30)
作者：Nan Bu, Zheng Dong, Lingfeng Zhang
期刊：Cancer Management and Research
影響因子 ：3.300
引用產(chǎn)品：CL-0120
-
FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in?vitro and in?vivo(2022/11/22)
作者：Kun Zhao, Jie Gao, Jihua Shi, Chengcheng Shi
期刊：Oncology Letters
影響因子 ：3.111
引用產(chǎn)品：CL-0120
-
ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression(2024/01/11)
作者：Meng Jin, Yang Mi, Fazhan Li
期刊：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI：10.1016/j.bbrc.2024.149515
影響因子 ：3.100
引用產(chǎn)品：CL-0120
-
Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis(2021/1/12)
作者：Lili Zhao, Ning Ma, Gaihong Liu
期刊：Digestive Diseases And Sciences
DOI：10.1007/s10620-020-06787-1
影響因子 ：3.100
-
IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC(2021/4/28)
作者：Yuan He, Jinhong Pei, Xueqing Li
期刊：Biochemical and Biophysical Research Communications
DOI：10.1016/j.bbrc.2021.04.050
影響因子 ：3.100
引用產(chǎn)品：CL-0120
-
Matrine inhibits cell proliferation, invasion, and stem cell formation in hepatocellular carcinoma by regulating the ELAVL1/RBM3-mediated Wnt/β-catenin signaling pathway(2024/01/23)
作者：Chunhua Song, Hongwei Li, Zhengchun Huang
期刊：Chemical Biology & Drug Design
影響因子 ：3.000
引用產(chǎn)品：CL-0120
-
let-7g sensitized liver cancer cells to 5-fluorouracil by downregulating ABCC10 expression(2023/12/06)
作者：Yun Chen, Bocheng Zhang, Cui Zhong
期刊：Chemical Biology & Drug Design
影響因子 ：3.000
引用產(chǎn)品：CL-0120
-
Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis(2023/08/15)
作者：Xiaoping Pan, Buren Jiya, Feng Wang
期刊：World Journal of Gastrointestinal Oncology
影響因子 ：3.000
-
miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing ERBB4 and TETs-dependent DNA demethylation(2021/08/26)
作者：Yuqiang Li,?Bin Wu,?Rongli Sun
期刊：Autoimmunity
DOI：10.1080/08916934.2021.1969552
影響因子 ：2.957
引用產(chǎn)品：CL-0120
-
Hyposterolactone A, a 3α-Hydroxy Steroidal Lactone from the Deep-Sea-Derived Fungus Hypocrea sp. ZEN14(2023/06/02)
作者：Lin Xu, Huabin Ma, Taizong Wu
期刊：CHEMISTRY & BIODIVERSITY
影響因子 ：2.900
-
Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression(2023/06/01)
作者：Jingru Zhang, Yang Liu, Xiaojie Wang
期刊：Oncology Letters
影響因子 ：2.900
引用產(chǎn)品：CL-0120
-
(2E)-1-(2,4,6-Trimethoxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one, a Chalcone Derivative, Promotes Apoptosis by Suppressing RAS-ERK and AKT/FOXO3a Pathways in Hepatocellular Carcinoma Cells(2023/06/14)
作者：Meigui Zhang, Jing Li, Ruixia Ma
期刊：CHEMISTRY & BIODIVERSITY
影響因子 ：2.900
-
Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β?catenin pathway in liver cancer(2023/08/30)
作者：Junying Wang, Guangyu Zhu
期刊：Oncology Letters
影響因子 ：2.900
引用產(chǎn)品：CL-0102 CL-0103 CL-0120 CL-0139 CL-0415 PB180120 PM150110 PM150210
-
Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular?carcinoma(2021/1/6)
作者：Danni Li, Shaogang Liu, Jiahao Zhu
期刊：BMC Pharmacology & Toxicology
DOI：10.1186/s40360-020-00461-y
影響因子 ：2.900
引用產(chǎn)品：CL-0120
-
USF1 modulates transcription and cellular functions by regulating multiple transcription factors in Huh7 cells(2023/10/30)
作者：Yanli Zeng, Fei Gao, Can Zhang
期刊：Oncology Letters
影響因子 ：2.900
引用產(chǎn)品：CL-0120
-
CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway(2021/07/14)
作者：Xitao Liu, Defang Zhao
期刊：Animal Cells and Systems
DOI：10.1080/19768354.2021.1953142
影響因子 ：2.900
-
Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3(2023/06/16)
作者：Zongqiang Hu, Yingpeng Zhao, Laibang Li
期刊：MOLECULAR BIOLOGY REPORTS
DOI：10.1007/s11033-023-08492-4
影響因子 ：2.800
-
CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway(2020/10/27)
作者：Jianqiang Bi, Quanle Liu, Yunchuan Sun
期刊：Journal Of Receptors And Signal Transduction
DOI：10.1080/10799893.2020.1837870
影響因子 ：2.800
引用產(chǎn)品：CL-0120
-
Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine(2023/12/07)
作者：Sheng Li, Xiaoliang Cai, Liang Chen
期刊：PeerJ
影響因子 ：2.700
引用產(chǎn)品：CL-0120
-
PAIP1 regulates expression of immune and inflammatory response associated genes at transcript level in liver cancer cell(2023/04/21)
作者：Jianfeng Zheng, Weiwei Fan, Xiaoyu Zhang
期刊：PeerJ
影響因子 ：2.700
-
Purpurogallin carboxylic acid exhibits synergistic effects with 5?fluorouracil on liver cancer cells in vitro by targeting ABCG2(2024/05/08)
作者：Pingping Zhao, Wei Liu, Shuqing Wang
期刊：Experimental and Therapeutic Medicine
影響因子 ：2.700
引用產(chǎn)品：CL-0120
-
Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma(2021/5/3)
作者：Qingqing Wang, Xiaoyan Yu, Zhewen Zheng
期刊：PeerJ
影響因子 ：2.700
-
Exosome-derived GTF2H2 from Huh7 cells can inhibit endothelial cell viability, migration, tube formation, and permeability(2022/09/08)
作者：Zhenkun Li, Yanmeng Li, Qin Ouyang
期刊：TISSUE & CELL
DOI：10.1016/j.tice.2022.101922
影響因子 ：2.600
引用產(chǎn)品：CL-0120
-
Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p(2021/11/19)
作者：Lan Gao, Xiufeng Zhang
期刊：Tissue & Cell
DOI：10.1016/j.tice.2021.101680
影響因子 ：2.600
-
Overexpression of PLK1 Molecule Following Incomplete Thermal Ablation Promotes the Proliferation and Invasion of Residual Hepatocellular Carcinoma(2024/05/23)
作者：Tong Kang, Jiamin Chen, Weijun Wan
期刊：MOLECULAR BIOTECHNOLOGY
DOI：10.1007/s12033-024-01181-y
影響因子 ：2.600
引用產(chǎn)品：CL-0120
-
LINC00665 target let-7i/HMGA1 promotes the proliferation and invasion of hepatoma cells(2024/02/07)
作者：Bochao Zhang, Siyuan Ma, Ping Zhu
期刊：MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
DOI：10.1016/j.mrfmmm.2024.111852
影響因子 ：2.300
引用產(chǎn)品：CL-0120
-
Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p/PDL1(2022/12/01)
作者：Suihui Li, Zhuangzhong Chen, Ruisheng Zhou
期刊：HISTOLOGY AND HISTOPATHOLOGY
影響因子 ：2.130
引用產(chǎn)品：CL-0120
-
CircRNA circBACH1 facilitates hepatitis B virus replication and hepatoma development by regulating the miR-200a-3p/MAP3K2 axis(2022/09/01)
作者：Na Du, Kailin Li, Yu Wang
期刊：HISTOLOGY AND HISTOPATHOLOGY
影響因子 ：2.130
引用產(chǎn)品：CL-0120
-
CircRNA circBACH1 facilitates hepatitis B virus replication and hepatoma development by regulating the miR-200a-3p/MAP3K2 axis.(2022/02/03)
作者：Du N, Li K, Wang Y
期刊：Histology And Histopathology
影響因子 ：2.000
-
PD-1/PD-L1 Interaction Upregulates YAP1 Expression in HepG2 Cells Through MAPK/ERK Pathway(2023/10/30)
作者：Shenghao Li, Muwei Dai, Fang Wang
期刊：Natural Product Communications
影響因子 ：1.800
引用產(chǎn)品：CL-0120
-
Network pharmacology prediction and experiment validation of anti liver cancer activity of curcumae rhizoma and hedyotis diffusa willd(2024/04/23)
作者：Songyan Tie, Tianhao Tong, Gangxiang Zhan
期刊：Annals of Medicine and Surgery
DOI：10.1097/MS9.0000000000002074
影響因子 ：1.700
引用產(chǎn)品：CL-0120
-
Integration of single-cell and bulk RNA-sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model(2023/11/22)
作者：Yaping Mu, Ding Zheng, Qinghua Peng
期刊：Cancer Reports
影響因子 ：1.700
引用產(chǎn)品：CL-0120
-
The diagnostic, prognostic, drug sensitivity and ceRNA internet of PPP4R1 in liver hepatocellular carcinoma (LIHC)(2024/02/26)
作者：Xiaowei Li, Yinglian Pan, Siren Feng
期刊：Translational Cancer Research
影響因子 ：0.900
引用產(chǎn)品：CL-0120
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
